Jacqueline E. SherbukEmi OkamotoMorgan A. MarksEnzo FortunyEva H. ClarkGerson Galdos‐CardenasAngel Vasquez-VillarAntonio B. FernándezThomas CrawfordQ. Rose2026-03-222026-03-22201510.1016/j.gheart.2015.07.003https://doi.org/10.1016/j.gheart.2015.07.003https://andeanlibrary.org/handle/123456789/44914Citaciones: 38Severe Chagas cardiomyopathy is associated with high short-term mortality. BNP, NT-proBNP, CK-MB, and MMP-2 have added predictive value for mortality, even in the presence of decreased ejection fraction and other clinical signs of congestive heart failure.enMedicineChecklistGlobal healthObservational studyStrengthening the reporting of observational studies in epidemiologyEpidemiologyFamily medicinePublic healthMedical educationBiomarkers and Mortality in Severe Chagas Cardiomyopathyarticle